Adicet Bio (ACET) Interest Expenses (2017 - 2026)
Adicet Bio (ACET) posted quarterly Interest Expenses of $15.0 million for Q1 2026, up 363.76% year-over-year from $3.2 million in Q1 2025, and up 62545.83% quarter-over-quarter from $24000.0 in Q4 2025.
Adicet Bio (ACET) Interest Expenses (2017 - 2026) Analysis & Trends
Adicet Bio's Interest Expenses history runs 10 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 363.76% year-over-year to $15.0 million; the TTM figure through Mar 2026 stood at $15.0 million (up 363.76% YoY), while the FY2025 annual figure was $140.5 million, up 17.8% from the prior year.
- Interest Expenses for Q1 2026 stood at $15.0 million, up from $24000.0 in the prior quarter.
- The five-year high for Interest Expenses was $30.8 million in Q1 2022, with the low at $24000.0 in Q4 2025.
- The 5-year median for Interest Expenses is $8.8 million (2023), against an average of $11.1 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses soared 15284.0% in 2022, then sank 99.4% in 2025.
- Adicet Bio's Interest Expenses stood at $3.8 million in 2022, then surged by 35.73% to $5.2 million in 2023, then decreased by 23.43% to $4.0 million in 2024, then tumbled by 99.4% to $24000.0 in 2025, then jumped by 62545.83% to $15.0 million in 2026.
- Business Quant data shows ACET's Interest Expenses at $15.0 million in Q1 2026, $24000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 93.62 Mn |
| 10 | Adicet Bio | 101.13 Mn | -17.06 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.97 Mn |
| Jun 30, 2026 | 13.97 Mn |
| Mar 31, 2026 | 15.04 Mn |
| Mar 31, 2026 | 15.04 Mn |
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 18.21 Mn |
| Jun 30, 2025 | 18.21 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 22.04 Mn |
| Sep 30, 2024 | 22.04 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 24.54 Mn |
| Mar 31, 2024 | 24.54 Mn |